403 Forbidden


nginx
403 Forbidden

403 Forbidden


nginx
Follow us:
403 Forbidden

403 Forbidden


nginx

Microsoft Pri0

Welcome to Microsoft Pri0: That's Microspeak for top priority, and that's the news and observations you'll find here from Seattle Times technology reporter Matt Day.

November 5, 2007 at 5:48 PM

Pro-Provenge group rides the bus

After placing an ad in the Washington Post and staging rallies in front of the Capitol and the FDA’s headquarters, activists angry at the agency’s decision to withhold approval for the prostate cancer drug Provenge have found a new way to voice their discontent.

Starting today, 25 Washington Metropolitan Area Transit buses will carry an ad headlined “Provenge Confidential.” The month-long campaign, styled as a poster for a film noir, is sponsored by CareToLive, a group that has sued the FDA for allegedly conspiring against the prostate cancer drug, developed by Seattle-based Dendreon. CareToLive is composed of patient activists as well as investors caught on the wrong side of Dendreon shares’ roller-coaster ride.

The ads make reference to “Machiavellian power grabs” and “undisclosed conflicts of interest” that supposedly led the FDA to request more data from Dendreon instead of approving it last May. An agency advisory panel had voted in favor of the drug.

The ads look like this:

dendreon.jpg

Other investors blame the company instead, claiming it didn’t communicate Provenge’s real chances of getting approved. The Securities and Exchange Commission has started an informal inquiry on the issue.

Comments | More in Biotechnology

COMMENTS

No personal attacks or insults, no hate speech, no profanity. Please keep the conversation civil and help us moderate this thread by reporting any abuse. See our Commenting FAQ.



The opinions expressed in reader comments are those of the author only, and do not reflect the opinions of The Seattle Times.


403 Forbidden

403 Forbidden


nginx
403 Forbidden

403 Forbidden


nginx